Showing results (61-70 of 95) with videos related to
Sort By:
Pageof 10
Journal of Medicinal Chemistry|September 30, 2005
Design, synthesis, and preliminary pharmacological evaluation of a set of small molecules that directly activate gi proteinsDina Manetti, Lorenzo Di Cesare Mannelli, Silvia Dei, et al.Bioorganic & Medicinal Chemistry|September 30, 2009
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancersElisabetta Martini, Alberto Salvicchi, Carla Ghelardini, et al.European Journal of Medicinal Chemistry|October 6, 2014
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl estersSilvia Dei, Marcella Coronnello, Elisa Floriddia, et al.Biochemical Pharmacology|March 22, 2016
Carbachol dimers as homobivalent modulators of muscarinic receptorsRosanna Matucci, Marta Nesi, Maria Vittoria Martino, et al.Journal of Medicinal Chemistry|October 21, 2022
New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer CellsLaura Braconi, Elisabetta Teodori, Chiara Riganti, et al.Journal of Medicinal Chemistry|August 28, 2010
Design, synthesis, and preliminary biological evaluation of new isoform-selective f-current blockersMichele Melchiorre, Martina Del Lungo, Luca Guandalini, et al.Molecular Pharmacology|June 14, 2023
Chemical, Pharmacological, and Structural Characterization of Novel Acrylamide-Derived Modulators of the GABA<sub>A</sub> ReceptorHugo R Arias, Spencer R Pierce, Allison L Germann, et al.Journal of Medicinal Chemistry|February 20, 2007
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structureSilvia Dei, Cristina Bellucci, Michela Buccioni, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 8, 2021
Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activationKatarzyna M Targowska-Duda, Barbara Budzynska, Agnieszka Michalak, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 12, 2025
Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT<sub>2A</sub> and mGlu<sub>2</sub> receptorsHugo R Arias, Laura Micheli, Anders A Jensen, et al.Pageof 10